• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

LAMP3 是一种与免疫行为相关的强有力的子宫体子宫内膜癌预后生物标志物。

LAMP3 is a potent uterine corpus endometrial carcinoma prognostic biomarker associated with immune behavior.

机构信息

Department of Obstetrics and Gynecology, Second Affiliated Hospital of Nanchang University, Nanchang, China.

Second College of Clinical Medicine, Nanchang University, Nanchang, China.

出版信息

Aging (Albany NY). 2024 Jan 11;16(1):714-745. doi: 10.18632/aging.205414.

DOI:10.18632/aging.205414
PMID:38217544
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10817406/
Abstract

BACKGROUND

Uterine corpus endometrial carcinoma (UCEC) is one of the most common gynecological malignancies and its incidence and mortality continue apace. Lysosome-associated membrane protein 3 (LAMP3) is the third member of the LAMP family and its overexpression has been described to be involved in the progression of breast, ovarian and cervical cancers, but there has been an absence of research focusing on its role in UCEC.

METHODS

WGCNA, TIMER, LinkedOmics, GSEA, Cytoscape, Kaplan-Meier plotter, GDC, GeneMANIA, cBioPortal, PDB, RNAinter, miRNet were applied in this research.

RESULTS

Our study uncovers that LAMP3 possesses higher expression levels in UCEC compared to normal tissues, and this differential expression profile is tightly aligned with clinical and pathological features, and patients demonstrating high LAMP3 expression tend to have a shorter survival expectancy. The high expression of LAMP3 is modulated by the designated ceRNA network. LAMP3 is engaged in UCEC progression by functioning in a variety of biological roles of relevance to immunity. Furthermore, we predicted several prospering drugs based on drug sensitivity. Finally, we also constructed possible docking patterns of LAMP3 with ABCA3, RAB9A, and SGTB.

CONCLUSIONS

LAMP3 is a formidable biomarker for UCEC and could be a prospective candidate for the diagnosis, treatment and prognostic assessment of UCEC.

摘要

背景

子宫内膜癌(UCEC)是最常见的妇科恶性肿瘤之一,其发病率和死亡率持续上升。溶酶体相关膜蛋白 3(LAMP3)是 LAMP 家族的第三个成员,其过表达被描述为参与乳腺癌、卵巢癌和宫颈癌的进展,但尚未有研究关注其在 UCEC 中的作用。

方法

本研究应用 WGCNA、TIMER、LinkedOmics、GSEA、Cytoscape、Kaplan-Meier plotter、GDC、GeneMANIA、cBioPortal、PDB、RNAinter、miRNet。

结果

我们的研究表明,LAMP3 在 UCEC 中的表达水平高于正常组织,这种差异表达谱与临床和病理特征密切相关,表达水平高的患者的预期生存时间较短。LAMP3 的高表达受特定的 ceRNA 网络调节。LAMP3 通过在与免疫相关的多种生物学作用中发挥作用,参与 UCEC 的进展。此外,我们基于药物敏感性预测了几种有前途的药物。最后,我们还构建了 LAMP3 与 ABCA3、RAB9A 和 SGTB 可能的对接模式。

结论

LAMP3 是 UCEC 的一种强大的生物标志物,可能是 UCEC 的诊断、治疗和预后评估的有前途的候选物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33b2/10817406/c09a614186bb/aging-16-205414-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33b2/10817406/efd73163a187/aging-16-205414-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33b2/10817406/2960a85d05a7/aging-16-205414-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33b2/10817406/0086b4b691c9/aging-16-205414-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33b2/10817406/1439a53a2827/aging-16-205414-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33b2/10817406/96f38c24fd26/aging-16-205414-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33b2/10817406/a37b429aa555/aging-16-205414-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33b2/10817406/a8c532d90d45/aging-16-205414-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33b2/10817406/923cfc30acd0/aging-16-205414-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33b2/10817406/76326ee243ed/aging-16-205414-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33b2/10817406/ab04329cc09f/aging-16-205414-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33b2/10817406/c09a614186bb/aging-16-205414-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33b2/10817406/efd73163a187/aging-16-205414-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33b2/10817406/2960a85d05a7/aging-16-205414-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33b2/10817406/0086b4b691c9/aging-16-205414-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33b2/10817406/1439a53a2827/aging-16-205414-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33b2/10817406/96f38c24fd26/aging-16-205414-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33b2/10817406/a37b429aa555/aging-16-205414-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33b2/10817406/a8c532d90d45/aging-16-205414-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33b2/10817406/923cfc30acd0/aging-16-205414-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33b2/10817406/76326ee243ed/aging-16-205414-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33b2/10817406/ab04329cc09f/aging-16-205414-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33b2/10817406/c09a614186bb/aging-16-205414-g011.jpg

相似文献

1
LAMP3 is a potent uterine corpus endometrial carcinoma prognostic biomarker associated with immune behavior.LAMP3 是一种与免疫行为相关的强有力的子宫体子宫内膜癌预后生物标志物。
Aging (Albany NY). 2024 Jan 11;16(1):714-745. doi: 10.18632/aging.205414.
2
TIMM8A is associated with dysfunction of immune cell in BRCA and UCEC for predicting anti-PD-L1 therapy efficacy.TIMM8A 与 BRCA 和 UCEC 免疫细胞功能障碍相关,可预测抗 PD-L1 治疗疗效。
World J Surg Oncol. 2022 Oct 7;20(1):336. doi: 10.1186/s12957-022-02736-6.
3
RNF183 Is a Prognostic Biomarker and Correlates With Tumor Purity, Immune Infiltrates in Uterine Corpus Endometrial Carcinoma.RNF183是一种预后生物标志物,与子宫内膜癌的肿瘤纯度和免疫浸润相关。
Front Genet. 2020 Nov 26;11:595733. doi: 10.3389/fgene.2020.595733. eCollection 2020.
4
A correlation study of adhesion G protein-coupled receptors as potential therapeutic targets in Uterine Corpus Endometrial cancer.黏附 G 蛋白偶联受体相关性研究及其作为子宫体子宫内膜癌潜在治疗靶点的价值。
Int Immunopharmacol. 2022 Jul;108:108743. doi: 10.1016/j.intimp.2022.108743. Epub 2022 Apr 9.
5
: A Prognostic Biomarker in Uterine Corpus Endometrial Carcinoma.: 子宫体子宫内膜癌的预后生物标志物。
Comb Chem High Throughput Screen. 2023;26(2):330-338. doi: 10.2174/1386207325666220404121856.
6
PPP1R14B is a diagnostic prognostic marker in patients with uterine corpus endometrial carcinoma.PPP1R14B 是子宫体子宫内膜癌患者的诊断预后标志物。
J Cell Mol Med. 2023 Mar;27(6):846-863. doi: 10.1111/jcmm.17697. Epub 2023 Feb 23.
7
Human gene family: potential tumor-associated antigens and biomarkers of prognosis in uterine corpus endometrial carcinoma.人类基因家族:子宫体子宫内膜癌中的潜在肿瘤相关抗原和预后标志物。
Oncotarget. 2023 May 4;14:426-437. doi: 10.18632/oncotarget.28409.
8
A pan-cancer analysis of prognostic significance and immunological role of lysosomal-associated membrane protein 3.泛癌症分析溶酶体相关膜蛋白 3 的预后意义和免疫作用。
J Cell Mol Med. 2024 Feb;28(3):e18088. doi: 10.1111/jcmm.18088. Epub 2023 Dec 26.
9
KDM4B, a potential prognostic biomarker revealed by large-scale public databases and clinical samples in uterine corpus endometrial carcinoma.大规模公共数据库和临床样本揭示的子宫体子宫内膜癌潜在预后生物标志物 KDM4B。
Mol Omics. 2022 Jul 11;18(6):506-519. doi: 10.1039/d1mo00287b.
10
Development and Clinical Validation of Novel 8-Gene Prognostic Signature Associated With the Proportion of Regulatory T Cells by Weighted Gene Co-Expression Network Analysis in Uterine Corpus Endometrial Carcinoma.基于加权基因共表达网络分析的与调节性 T 细胞比例相关的新型 8 基因预后标志物在子宫体子宫内膜癌中的开发与临床验证。
Front Immunol. 2021 Dec 14;12:788431. doi: 10.3389/fimmu.2021.788431. eCollection 2021.

引用本文的文献

1
Independent organelle and organelle-organelle interactions: essential mechanisms for malignant gynecological cancer cell survival.独立细胞器和细胞器-细胞器相互作用:恶性妇科癌症细胞存活的必要机制。
Front Immunol. 2024 Apr 22;15:1393852. doi: 10.3389/fimmu.2024.1393852. eCollection 2024.

本文引用的文献

1
A novel predictive model based on inflammatory response-related genes for predicting endometrial cancer prognosis and its experimental validation.基于炎症反应相关基因的新型预测模型用于预测子宫内膜癌的预后及其实验验证。
Aging (Albany NY). 2023 Jun 5;15(11):4844-4860. doi: 10.18632/aging.204767.
2
The gene signature of tertiary lymphoid structures within ovarian cancer predicts the prognosis and immunotherapy benefit.卵巢癌中三级淋巴结构的基因特征可预测预后及免疫治疗疗效。
Front Genet. 2023 Jan 10;13:1090640. doi: 10.3389/fgene.2022.1090640. eCollection 2022.
3
Bioinformatics identification of miR-514b-5p promotes NSCLC progression and induces PI3K/AKT and p38 pathways by targeting small glutamine-rich tetratricopeptide repeat-containing protein beta.
通过靶向富含小谷氨酰胺的四肽重复序列蛋白β,miR-514b-5p的生物信息学鉴定促进非小细胞肺癌进展并诱导PI3K/AKT和p38信号通路。
FEBS J. 2023 Feb;290(4):1134-1150. doi: 10.1111/febs.16639. Epub 2022 Oct 21.
4
LHX1 as a potential biomarker regulates EMT induction and cellular behaviors in uterine corpus endometrial carcinoma.LHX1 作为一种潜在的生物标志物,调节子宫体子宫内膜癌中的 EMT 诱导和细胞行为。
Clinics (Sao Paulo). 2022 Sep 15;77:100103. doi: 10.1016/j.clinsp.2022.100103. eCollection 2022.
5
The Regulatory Role of Lipid Metabolism in Endometrial Cancer.脂质代谢在子宫内膜癌中的调节作用
J Oncol. 2022 Aug 29;2022:6458877. doi: 10.1155/2022/6458877. eCollection 2022.
6
BHLHE22 Expression Is Associated with a Proinflammatory Immune Microenvironment and Confers a Favorable Prognosis in Endometrial Cancer.BHLHE22 的表达与促炎免疫微环境相关,并赋予子宫内膜癌有利的预后。
Int J Mol Sci. 2022 Jun 28;23(13):7158. doi: 10.3390/ijms23137158.
7
Identification of SHCBP1 as a potential biomarker involving diagnosis, prognosis, and tumor immune microenvironment across multiple cancers.鉴定SHCBP1作为一种潜在的生物标志物,涉及多种癌症的诊断、预后及肿瘤免疫微环境。
Comput Struct Biotechnol J. 2022 Jun 18;20:3106-3119. doi: 10.1016/j.csbj.2022.06.039. eCollection 2022.
8
The Circadian Gene NPAS2 Act as a Putative Tumor Stimulative Factor for Uterine Corpus Endometrial Carcinoma.昼夜节律基因NPAS2作为子宫体子宫内膜癌的一种假定肿瘤刺激因子。
Cancer Manag Res. 2021 Dec 22;13:9329-9343. doi: 10.2147/CMAR.S343097. eCollection 2021.
9
HE4 as a Biomarker for Endometrial Cancer.人附睾蛋白4作为子宫内膜癌的生物标志物
Cancers (Basel). 2021 Sep 23;13(19):4764. doi: 10.3390/cancers13194764.
10
Web-Based Survival Analysis Tool Tailored for Medical Research (KMplot): Development and Implementation.专为医学研究量身定制的基于网络的生存分析工具(KMplot):开发与应用
J Med Internet Res. 2021 Jul 26;23(7):e27633. doi: 10.2196/27633.